GB9720052D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB9720052D0 GB9720052D0 GBGB9720052.1A GB9720052A GB9720052D0 GB 9720052 D0 GB9720052 D0 GB 9720052D0 GB 9720052 A GB9720052 A GB 9720052A GB 9720052 D0 GB9720052 D0 GB 9720052D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9720052.1A GB9720052D0 (en) | 1997-09-19 | 1997-09-19 | Novel compounds |
EP98951421A EP1017694A2 (en) | 1997-09-19 | 1998-09-15 | N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |
PCT/EP1998/005904 WO1999015526A2 (en) | 1997-09-19 | 1998-09-15 | N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |
CA002303994A CA2303994A1 (en) | 1997-09-19 | 1998-09-15 | N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |
JP2000512831A JP2001517668A (ja) | 1997-09-19 | 1998-09-15 | N−5,6,7,8−テトラヒドロ(1、6)ナフチリジン−n’−フェニルウレア誘導体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9720052.1A GB9720052D0 (en) | 1997-09-19 | 1997-09-19 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9720052D0 true GB9720052D0 (en) | 1997-11-19 |
Family
ID=10819406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9720052.1A Ceased GB9720052D0 (en) | 1997-09-19 | 1997-09-19 | Novel compounds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1017694A2 (ja) |
JP (1) | JP2001517668A (ja) |
CA (1) | CA2303994A1 (ja) |
GB (1) | GB9720052D0 (ja) |
WO (1) | WO1999015526A2 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2425625A1 (en) * | 2000-10-12 | 2002-07-18 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
ES2287170T3 (es) | 2000-10-12 | 2007-12-16 | MERCK & CO., INC. | Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa. |
WO2002030930A2 (en) | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
JP2005504807A (ja) | 2001-09-26 | 2005-02-17 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 抗糖尿病薬としての1,8−ナフチリジン誘導体 |
WO2003077850A2 (en) | 2002-03-15 | 2003-09-25 | Merck & Co., Inc. | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
US8629276B2 (en) * | 2012-02-15 | 2014-01-14 | Bristol-Myers Squibb Company | Inhibitors of human immunodeficiency virus replication |
EP3097101B1 (en) | 2014-01-24 | 2020-12-23 | Merck Sharp & Dohme Corp. | Isoquinoline derivatives as mgat2 inhibitors |
JP6972384B2 (ja) * | 2018-11-28 | 2021-11-24 | 武田薬品工業株式会社 | 複素環化合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1302662B (ja) * | 1971-02-04 | |||
GB1574019A (en) * | 1977-01-14 | 1980-09-03 | Joullie International Sa | Therapeutically useful 3,4,5-trimethoxybenzene derivatives |
US4542144A (en) * | 1981-11-16 | 1985-09-17 | Mcneilab Inc. | Anticonvulsant N-aryl-N'-(2-thiazolidinylidene)ureas |
PT77429B (fr) * | 1982-10-05 | 1986-02-27 | Cortial | Procede pour preparer de nouvelles n-(amino-methyl-5 oxazolin-2 yl-2)n'-phenylurees et de compositions les contenant |
US5378848A (en) * | 1992-02-12 | 1995-01-03 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
DK41193D0 (da) * | 1993-04-07 | 1993-04-07 | Neurosearch As | Ionkanalaabnere |
GB9511355D0 (en) * | 1995-06-06 | 1995-08-02 | Fujisawa Pharmaceutical Co | Urea derivatives |
-
1997
- 1997-09-19 GB GBGB9720052.1A patent/GB9720052D0/en not_active Ceased
-
1998
- 1998-09-15 EP EP98951421A patent/EP1017694A2/en not_active Withdrawn
- 1998-09-15 CA CA002303994A patent/CA2303994A1/en not_active Abandoned
- 1998-09-15 WO PCT/EP1998/005904 patent/WO1999015526A2/en not_active Application Discontinuation
- 1998-09-15 JP JP2000512831A patent/JP2001517668A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO1999015526A2 (en) | 1999-04-01 |
JP2001517668A (ja) | 2001-10-09 |
EP1017694A2 (en) | 2000-07-12 |
WO1999015526A3 (en) | 1999-05-20 |
CA2303994A1 (en) | 1999-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24412A (en) | Novel compounds | |
EG24177A (en) | Novel compounds | |
GB9701684D0 (en) | Novel compounds | |
GB9706255D0 (en) | Novel compounds | |
GB9720052D0 (en) | Novel compounds | |
GB9707830D0 (en) | Novel compounds | |
GB9712581D0 (en) | Novel compounds | |
GB9701597D0 (en) | Novel compounds | |
GB9708095D0 (en) | Novel compounds | |
GB9708062D0 (en) | Novel compounds | |
GB9700687D0 (en) | Novel compounds | |
GB9700688D0 (en) | Novel compounds | |
GB9700689D0 (en) | Novel compounds | |
GB9700590D0 (en) | Novel compounds | |
GB9708034D0 (en) | Novel compounds | |
GB9700694D0 (en) | Novel compounds | |
GB9707876D0 (en) | Novel compounds | |
GB9700281D0 (en) | Novel compounds | |
GB9707875D0 (en) | Novel compounds | |
GB9707874D0 (en) | Novel compounds | |
GB9707873D0 (en) | Novel compounds | |
GB9709085D0 (en) | Novel compounds | |
GB9700901D0 (en) | Novel compounds | |
GB9709089D0 (en) | Novel compounds | |
GB9709463D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |